Covid-19 roundup: Merck prepares to put vaccines into the clinic; Remdesivir keeps Gilead sales afloat
Alluvial Fund 2Q20: Long Bredband2 i Skandinavien
Brutal Consequences - Blain Warns "There Are Seriously Large Icebergs Ahead"
"It's Shocking No Matter How You Look At It" - Futures Jump On Blockbuster Tech Earnings; Gold Hits New Record High
'Partial' Lockdowns Expand In Europe, New COVID-19 Cases Climb In China, Hong Kong: Live Updates
Vaccine Effectiveness Could be Boosted in the Elderly
Malaria Transport Channel Identified Connecting Parasite to Red Blood Cell
Hong Kong Cancels Fall Election As Coronavirus "Third Wave" Intensifies
Covid-19 roundup: Despite Q2 sales setback, Gilead revises 2020 sales projection upward thanks to remdesivir
Macro Briefing | 31 July 2020
Coronavirus pharma news roundup – 31/07/20
Molson Coors Delivers Q2 Earnings Beat Despite Covid-19 Fallout
Daily Market News: FAANGs thrive as US economy drowns
Face mask rules: do they really violate personal liberty?
Apple announces a 4 for 1 stock split
"There Is No Proven Effectiveness" - Netherlands Refuses To Mandate Mask Wearing In Public
Apple Up 6% On Blowout Quarter; Strong iPhone Demand
Exclusive: Chinese-backed hackers targeted COVID-19 vaccine firm Moderna
A Post-Brexit Agrochemical Apocalypse For The UK?
Domestic Violence More Than Doubled Under Lockdowns, New Study Finds
Despite Mixed International Recovery, McDonald’s Stock Will Bounce Back, Says Top Analyst
Amazon Soars After Smashing Expectations, Guiding Sharply Higher
Figures of the week: Regional heterogeneity in Africa’s economic growth predicted to subside
How we rely on older adults, especially during the coronavirus pandemic
Gold ETFs prosper as price flirts with $2,000/oz mark
Pullback from record high gold price needed for $2,000 an ounce
Aphria Stock Tumbles 19%, Blames Covid To Cover Up Fraud
Oil demand
Study puts Jardiance in hot pursuit of AZ’s Farxiga in heart failure
Coronavirus Lockdowns At What Price And At Whose Cost?
